Skip to main content

Table 4 Preference shares

From: Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism

 

Surgery or Medication

Chance That the Treatment Keeps Your Labs Within Their Recommended Ranges

Chance that the Treatment Relieves Your HPT Symptoms

Risk of Low Blood Calcium

Nausea and Vomiting

How You Receive the Medicine

Out-of-Pocket Cost of Treatment per Month

Predicted Preference Share

(95% CI)

Scenario 1: two medications, $15 out-of-pocket cost

 Treatment profile 1

Medication

60 out of 100 (60%)

35 out of 100 (35%)

2 out of 100 (2%)

Mild

Given through dialysis line during your regular dialysis treatment

$15

60.8% (54.6%–67.0%)

 Treatment profile 2

Medication

60 out of 100 (60%)

35 out of 100 (35%)

2 out of 100 (2%)

Mild

Pill once a day

$15

39.2% (33.0%–45.4%)

Scenario 2: two medications and surgery, $15 out-of-pocket cost of medications

 Treatment profile 1

Medication

60 out of 100 (60%)

35 out of 100 (35%)

2 out of 100 (2%)

Mild

Given through dialysis line during your regular dialysis treatment

$15

60.0% (53.8%–66.2%)

 Treatment profile 2

Medication

60 out of 100 (60%)

35 out of 100 (35%)

2 out of 100 (2%)

Mild

Pill once a day

$15

38.7% (32.6%–44.8%)

 Treatment profile 3

Surgery

60 out of 100 (60%)

35 out of 100 (35%)

2 out of 100 (2%)

[Not applicable]

[Not applicable]

$0 (surgery is defined as a one-time cost of $500, which is reflected in the preference weight for surgery)

1.3% (0.1%–2.5%)

  1. CI confidence interval, SHPT secondary hyperparathyroidism